Drug Approvals
🇺🇸 FDA Page 18FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 205–216 of 665 articles
Top 10 Takeover Targets of 2026: Market Analysis
Commissioner's National Priority Voucher Pilot Program: Clinical Trials Insights
FDA Considers Adding Peptides to Bulk Drug Compounding List
Healthcare Dealmakers Target Megamergers in 2026
FSMA Final Rule: New Traceability Requirements Impacting Food Safety
FDA Guidance on Next-Gen Sequencing for Gene Therapy Safety
Friday Five: Key Regulatory Updates in Pharma
Zydus Lifesciences Secures FDA Priority Review for Liver Disease Drug
Chinese Pharma Innovators Expand Globally with Innovative Deal Structures
Global M&A Trends in Health Industries: 2026 Outlook
altRx GLP-1 Review 2026: FDA Updates on Semaglutide
Replimune's Third FDA Approval Attempt and Pfizer's China Deal